|Other Names||Matrix metalloproteinase-21, MMP-21, 3424-, MMP21|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7497b was selected from the C-term region of human MMP21. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May have an important and specific function in tumor progression and embryogenesis. Cleaves alpha-1-antitrypsin.|
|Tissue Location||Identified in fetal brain, kidney and liver. In adult tissues found primarily in ovary, kidney, liver, lung, placenta, brain and peripheral blood leukocytes. Expressed as well in various cancer cell lines.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
MMP21 is a member of the matrix metalloproteinase family. Proteins in this family are involved in the breakdown of extracellular matrix for both normal physiological processes, such as embryonic development, reproduction, and tissue remodeling,and disease processes, such as asthma and metastasis. The protein may play an important role in embryogenesis, particularly in neuronal cells, as well as in lymphocyte development and survival.
Skoog,T., Elomaa,O. J. Invest. Dermatol. 129 (1), 119-130 (2009)Qiu,W., Zhou,G. Cancer Epidemiol. Biomarkers Prev. 17 (9), 2514-2518 (2008)Bister,V., Skoog,T. Mod. Pathol. 20 (11), 1128-1140 (2007)Skoog,T., Ahokas,K. Exp. Dermatol. 15 (10), 775-783 (2006)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.